DiLisio, James E. and Haskins, Kathryn (2021) Induction of Antigen-Specific Tolerance in Autoimmune Diabetes with Nanoparticles Containing Hybrid Insulin Peptides. Biomedicines, 9 (3). p. 240. ISSN 2227-9059
![[thumbnail of biomedicines-09-00240-v2.pdf]](http://uploads.submit4manuscript.com/style/images/fileicons/text.png)
biomedicines-09-00240-v2.pdf - Published Version
Download (571kB)
Abstract
Autoreactive T cells are thought to orchestrate the onset and progression of autoimmune diabetes. Key cognate antigens of these diabetogenic T cells include hybrid insulin peptides, formed by the fusion of insulin fragments to cleavage products of other β-cell granule proteins. Here we review initial work exploring tolerance induction to a hybrid insulin peptide using a biodegradable, nanoparticle delivery system in non-obese diabetic (NOD) mice. The immune phenotype(s) and possible mechanism(s) behind antigen-specific tolerance induction were dissected with a disease transfer model using transgenic autoreactive mouse T cells. Treatment of NOD mice with peptide-coupled nanoparticles appeared to have a dual function in preventing diabetes onset, inducing anergy in effector T cells and enhancing the activity of regulatory T cells. Importantly, the ratio of these two cell types in the pancreas was pushed toward tolerance. Antigen-specific tolerance induction to hybrid insulin peptides has the translational potential to preserve islet β-cells in new-onset or at-risk patients and prevent recurrent autoimmunity in transplant patients.
Item Type: | Article |
---|---|
Subjects: | South Asian Archive > Biological Science |
Depositing User: | Unnamed user with email support@southasianarchive.com |
Date Deposited: | 19 Jan 2023 12:33 |
Last Modified: | 20 Mar 2025 04:58 |
URI: | http://uploads.submit4manuscript.com/id/eprint/19 |